Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

IOVA Iovance Biotherapeutics Inc

6,30

0,11 (1,78%)

25 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Iovance Biotherapeutics Charts.

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Iovance Biotherapeutics Charts.

News Iovance Biotherapeutics Inc

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Freitag 17 Januar 2025 (1 Woche vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 17 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 16 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Freitag 20 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 18 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Freitag 13 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 4 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 4 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 4 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Montag 2 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer
Dienstag 26 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 21 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Iovance Biotherapeutics Inc News-Artikel

BNP Paribas Issuance

Societe Generale Effekten

WisdomTree Commodity Sec...

Nlrent0 15jan37

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen